Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
She/her Paola Alberti
Assistant Professor - University of Milano-Bicocca
Professional Bio
MD, PhD, Board in Neurology. She is an Assistant Professor (Human Anatomy) at University of Milano-Bicocca and Consultant Neurologist at Fondazione IRCCS San Gerardo dei Tintori (Monza, Italy).
Her main expertise is related to peripheral nervous system diseases, especially Chemotherapy Induced Peripheral Neurotoxicity (CIPN). She is an active member of the Toxic Neuropathy Consortium (TNC), part of the Peripheral Nervous System (PNS) society. During the Residency in Neurology, she was a visiting fellow at Johns Hopkins University (Prof. D.R. Cornblath, MD) to refine her knowledge of neurophysiological techniques. Since 2015 she has been pursuing an interest for preclinical research and joined the Experimental Neurology Unit (ENU, University of Milano-Bicocca) team, where she completed the PhD program in Neuroscience (2019). Her PhD project was focused on Oxaliplatin Induced Peripheral Neurotoxicity in preclinical models: she introduced advanced neurophysiological techniques, nerve excitability testing, to ENU after having learnt them from Prof H. Bostock, (UCL, London). She was a visiting fellow at University of Baltimore (Prof. S.G. Dorsey and Prof C. Renn) where learned DRG recordings in preclinical models. Since August 2016 she is a consultant Neurologist at San Gerardo Hospital (IRCCS San Gerardo, Monza, Italy): she is the treating physician for outpatients affected by CIPN. She is the PI in this Center for the INTERNATIONAL CHEMOTHERAPY-INDUCED NEUROTOXICITY (CIPN) ASSESSMENT AND VALIDATION STUDY (ICAVS) which involves 30 Centers around the globe (US, Canada, South America, Africa, India, Australia). In the same Center, she is also PI of the CIPN COST study (www.cipncare.com), aiming at ascertaining socio-economic burden related to CIPN (awarded a 115,000 euros grant, by UNIMIB), and of the NEUPER study, aiming at ascertain efficacy of physical treatment to reverse sensory ataxia due to polyneuropathy. She is responsible for human anatomy teaching courses (at UNIMIB since 2016 and at Lunex University in 2020). In 2022 she received a personal grant of 250,000 euros from Fondazione Cariplo to carry out a 3-year preclinical project, entitled Sodium-calcium exchanger (NCX) and ion channels: pivotal elements leading to axonal damage in peripheral nerves?, with the aim of investigating mechanisms of axonopathy with a translational approach.
H-index (Scopus): 33.
Her main expertise is related to peripheral nervous system diseases, especially Chemotherapy Induced Peripheral Neurotoxicity (CIPN). She is an active member of the Toxic Neuropathy Consortium (TNC), part of the Peripheral Nervous System (PNS) society. During the Residency in Neurology, she was a visiting fellow at Johns Hopkins University (Prof. D.R. Cornblath, MD) to refine her knowledge of neurophysiological techniques. Since 2015 she has been pursuing an interest for preclinical research and joined the Experimental Neurology Unit (ENU, University of Milano-Bicocca) team, where she completed the PhD program in Neuroscience (2019). Her PhD project was focused on Oxaliplatin Induced Peripheral Neurotoxicity in preclinical models: she introduced advanced neurophysiological techniques, nerve excitability testing, to ENU after having learnt them from Prof H. Bostock, (UCL, London). She was a visiting fellow at University of Baltimore (Prof. S.G. Dorsey and Prof C. Renn) where learned DRG recordings in preclinical models. Since August 2016 she is a consultant Neurologist at San Gerardo Hospital (IRCCS San Gerardo, Monza, Italy): she is the treating physician for outpatients affected by CIPN. She is the PI in this Center for the INTERNATIONAL CHEMOTHERAPY-INDUCED NEUROTOXICITY (CIPN) ASSESSMENT AND VALIDATION STUDY (ICAVS) which involves 30 Centers around the globe (US, Canada, South America, Africa, India, Australia). In the same Center, she is also PI of the CIPN COST study (www.cipncare.com), aiming at ascertaining socio-economic burden related to CIPN (awarded a 115,000 euros grant, by UNIMIB), and of the NEUPER study, aiming at ascertain efficacy of physical treatment to reverse sensory ataxia due to polyneuropathy. She is responsible for human anatomy teaching courses (at UNIMIB since 2016 and at Lunex University in 2020). In 2022 she received a personal grant of 250,000 euros from Fondazione Cariplo to carry out a 3-year preclinical project, entitled Sodium-calcium exchanger (NCX) and ion channels: pivotal elements leading to axonal damage in peripheral nerves?, with the aim of investigating mechanisms of axonopathy with a translational approach.
H-index (Scopus): 33.
